NYSE:ABTMedical Equipment
Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness and Modest Undervaluation Estimate
Event context and recent performance
Abbott Laboratories (ABT) has been drawing investor attention after a period where the stock has delivered a one month return of about a 2% decline and a past 3 months return of roughly a 13% decline.
Against this backdrop, the company’s current share price near $109.95, a recent one day gain of about 2%, and mixed longer term total returns are prompting closer scrutiny of how its diversified healthcare business and earnings profile line up with today’s...